carbidopa has been researched along with Cerebral Palsy in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gelfius, CD; Mortimer, D; Potts, MA | 1 |
Birthi, P; McDowell, S; Perry, D; Salles, S | 1 |
Blau, N; Connolly, MB; Demos, MK; Hyland, K; Lillquist, Y; Makhseed, N; Vallance, HD; Waters, PJ | 1 |
Chutorian, AM; Levine, RA; Naini, AB; Nygaard, TG; Waran, SP | 1 |
Bakhteev, KK; Brin, IL | 1 |
Brin, IL; Mashilov, KV | 1 |
Sethy, VH; Van Woert, MH | 1 |
Evtushenko, SK; Mogilevskaia, GS; Osadchiĭ, VG; Ostropolets, SS; Prokhorova, LM; Sadekov, IA; Samsonenko, RA; Va'skovskaia, ME | 1 |
Barton, NW; Cohen, WE; Filling-Katz, MR; Fink, JK; Hallett, M; Macrae, PR | 1 |
1 trial(s) available for carbidopa and Cerebral Palsy
Article | Year |
---|---|
[Clinical results of using Nakom in diseases of the nervous system].
Topics: Adolescent; Adult; Age Factors; Carbidopa; Catecholamines; Cerebral Palsy; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Dystonia Musculorum Deformans; Humans; Levodopa; Muscle Rigidity; Myasthenia Gravis | 1989 |
8 other study(ies) available for carbidopa and Cerebral Palsy
Article | Year |
---|---|
Deleterious cognitive and motoric effects of haloperidol in an adolescent with cerebral palsy: a case report.
Topics: Adolescent; Amantadine; Carbidopa; Cerebral Palsy; Cognition Disorders; Dopamine Agonists; Dopamine Antagonists; Drug Combinations; Haloperidol; Humans; Levodopa; Male; Psychomotor Disorders | 2013 |
Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy.
Topics: Carbidopa; Cerebral Palsy; Child; Dopamine Agents; Drug Therapy, Combination; Dystonia; Follow-Up Studies; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome | 2012 |
6-pyruvoyl-tetrahydropterin synthase deficiency with mild hyperphenylalaninemia.
Topics: 5-Hydroxytryptophan; Biopterins; Carbidopa; Cerebral Palsy; Child; Developmental Disabilities; Diagnostic Errors; Dopamine Agents; Female; Humans; Levodopa; Movement Disorders; Phenylalanine; Phenylketonurias; Phosphorus-Oxygen Lyases; Seizures | 2005 |
Dopa-responsive dystonia simulating cerebral palsy.
Topics: Adolescent; Adult; Biopterins; Carbidopa; Cerebral Palsy; Child; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Dystonia; Female; Follow-Up Studies; Homovanillic Acid; Humans; Levodopa; Male; Neopterin; Neurologic Examination; Parkinson Disease, Secondary | 1994 |
[Changes in the indices of standing and walking in patients with infantile cerebral palsy under the influence of low doses of Nakom].
Topics: Adolescent; Antiparkinson Agents; Carbidopa; Cerebral Palsy; Child; Dose-Response Relationship, Drug; Drug Combinations; Female; Gait; Humans; Levodopa; Male; Posture; Walking | 1995 |
[The effect of low doses of nakom on the hormonal secretion of the hypothalamo-hypophyseal-adrenal system in patients with infantile cerebral palsy].
Topics: Adolescent; Adrenal Cortex Hormones; Carbidopa; Cerebral Palsy; Child; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hypothalamic Hormones; Hypothalamo-Hypophyseal System; Levodopa; Male; Pituitary Hormones; Pituitary-Adrenal System | 1996 |
Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Cerebral Palsy; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Hypoxia; Male; Methysergide; Middle Aged; Myoclonus; Probenecid; Serotonin | 1975 |
Treatable dystonia presenting as spastic cerebral palsy.
Topics: Adolescent; Adult; Carbidopa; Cerebral Palsy; Child; Child, Preschool; Diagnosis, Differential; Dystonia; Humans; Levodopa; Muscle Spasticity | 1988 |